Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Be The Envy LLC currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action, which represents the entirety of its active prosecution workload. This matter is assigned to 1 distinct examiner, indicating a concentrated prosecution strategy for this specific portfolio.
The busiest examiner for the company is CONIGLIO, AUDREA JUNE BUCKLEY, who is responsible for the 1 busiest examiner pending office action. Because 1 distinct art unit is involved, the prosecution environment is specialized rather than distributed across multiple USPTO divisions. This concentration suggests that the legal strategy is currently focused on a narrow technical field within the broader Biotechnology & Pharmaceuticals sector.
With 1 distinct examiner overseeing the pending workload, the outcome of the current prosecution cycle depends on the interactions with this specific individual. The presence of 1 pending office action in 1 distinct art unit simplifies the administrative tracking for the portfolio, as there are no competing deadlines or divergent examiner behaviors to manage across different units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 52.9% | +21.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18951028 | LIP STAIN PRODUCT AND METHOD OF APPLICATION | CONIGLIO, AUDREA JUNE BUCKLEY | 46d overdue |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18951028 | LIP STAIN PRODUCT AND METHOD OF APPLICATION | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103 | Final Rejection | 46d overdue | Pending | Nov 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial